1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with amyloid beta-peptides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antkiewicz-Michaluk, L; Kuszczyk, MA; Lazarewicz, JW; Sadowski, MJ | 1 |
1 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and amyloid beta-peptides
Article | Year |
---|---|
1MeTIQ provides protection against Aβ-induced reduction of surface expression of synaptic proteins and inhibits H₂O₂-induced oxidative stress in primary hippocampal neurons.
Topics: Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Disks Large Homolog 4 Protein; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Guanylate Kinases; Hippocampus; Hydrogen Peroxide; Membrane Proteins; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptophysin; Tetrahydroisoquinolines | 2014 |